These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12188883)

  • 1. Selectively replicating adenoviruses for oncolytic therapy.
    Yoon TK; Shichinohe T; Laquerre S; Kasahara N
    Curr Cancer Drug Targets; 2001 Aug; 1(2):85-107. PubMed ID: 12188883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replicative oncolytic adenoviruses in multimodal cancer regimens.
    Post DE; Khuri FR; Simons JW; Van Meir EG
    Hum Gene Ther; 2003 Jul; 14(10):933-46. PubMed ID: 12869212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replicating adenoviruses in cancer therapy.
    Dobbelstein M
    Curr Top Microbiol Immunol; 2004; 273():291-334. PubMed ID: 14674605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer gene therapy with oncolytic adenoviruses.
    Guse K; Hemminki A
    J BUON; 2009 Sep; 14 Suppl 1():S7-15. PubMed ID: 19785073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of replicating oncolytic adenoviruses in combination therapy for cancer.
    Chu RL; Post DE; Khuri FR; Van Meir EG
    Clin Cancer Res; 2004 Aug; 10(16):5299-312. PubMed ID: 15328165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter four--Design of improved oncolytic adenoviruses.
    Alemany R
    Adv Cancer Res; 2012; 115():93-114. PubMed ID: 23021243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis.
    Nettelbeck DM
    Anticancer Drugs; 2003 Sep; 14(8):577-84. PubMed ID: 14501378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.
    Dalba C; Klatzmann D; Logg CR; Kasahara N
    Curr Gene Ther; 2005 Dec; 5(6):655-67. PubMed ID: 16457654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in research on oncolytic adenoviruses in tumor therapy].
    Zhou XL; Tang WR
    Bing Du Xue Bao; 2014 May; 30(3):318-24. PubMed ID: 25118389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectively replicating oncolytic adenoviruses as cancer therapeutics.
    Yu DC; Working P; Ando D
    Curr Opin Mol Ther; 2002 Oct; 4(5):435-43. PubMed ID: 12435044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].
    Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
    Kim J; Cho JY; Kim JH; Jung KC; Yun CO
    Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
    Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
    J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of transcriptionally regulated oncolytic adenoviruses.
    Ko D; Hawkins L; Yu DC
    Oncogene; 2005 Nov; 24(52):7763-74. PubMed ID: 16299536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific promoters for cancer gene therapy.
    Saukkonen K; Hemminki A
    Expert Opin Biol Ther; 2004 May; 4(5):683-96. PubMed ID: 15155160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus vectors for gene therapy, vaccination and cancer gene therapy.
    Wold WS; Toth K
    Curr Gene Ther; 2013 Dec; 13(6):421-33. PubMed ID: 24279313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication-selective oncolytic viruses in the treatment of cancer.
    Everts B; van der Poel HG
    Cancer Gene Ther; 2005 Feb; 12(2):141-61. PubMed ID: 15472714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.